| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2022 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 51 | $23.44 | $1,195.44 | -0.1% | -15.8% | -44.0% | |
| Aug 31, 2022 | VERO Venus Concept Inc. | Serafino Domenic | Chief Executive Officer | Buy | 75,000 | $0.33 | $25,023.75 | +3.9% | -21.7% | -62.2% | |
| Aug 31, 2022 | STSS Sharps Technology Inc. | Hayes Robert Michael | Chief Executive Officer | Buy | 8,073 | $1.35 | $10,867.37 | +2.0% | +2.4% | -39.8% | |
| Aug 30, 2022 | NXGL Nexgel, Inc. | Spinrad Yaakov | Director | Buy | 1,648 | $1.68 | $2,768.64 | New | -30.4% | +45.8% | |
| Aug 30, 2022 | NXGL Nexgel, Inc. | Stefansky David54 | Director | Buy | 5,000 | $1.66 | $8,280.00 | +22.1% | -30.4% | +45.8% | |
| Aug 30, 2022 | TMCI Treace Medical Concepts, Inc. | Bays F Barry80 | Director | Sell | 11,864 | $20.11 | $238,636.24 | -0.3% | +13.9% | -16.8% | |
| Aug 30, 2022 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 1,746 | $3.83 | $6,692.88 | -0.3% | -10.9% | -73.7% | |
| Aug 30, 2022 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 5,233 | $3.83 | $20,059.47 | -0.3% | -10.9% | -73.7% | |
| Aug 30, 2022 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | President And CEO | Sell | 17,871 | $3.83 | $68,467.27 | -0.5% | -10.9% | -73.7% | |
| Aug 30, 2022 | RBOT Vicarious Surgical Inc. | Morris June89 | CLO, GC And Secretary | Sell | 1,728 | $3.83 | $6,623.88 | -0.3% | -10.9% | -73.7% | |
| Aug 29, 2022 | APYX Apyx Medical Corp | Goodwin Charles D. II | Chief Executive Officer | Buy | 11,750 | $5.96 | $70,067.50 | +20.1% | -70.2% | -22.4% | |
| Aug 29, 2022 | ATEC Alphatec Holdings, Inc. | Mowry David H53 | Director | Sell | 4,370 | $7.85 | $34,304.50 | -4.5% | +22.1% | +100.6% | |
| Aug 29, 2022 | UFPT Ufp Technologies Inc | Litterio Christopher P. | Senior Vice President | Sell | 5,500 | $95.90 | $527,450.00 | -27.3% | +21.6% | +84.5% | |
| Aug 29, 2022 | STSS Sharps Technology Inc. | Hayes Robert Michael | Chief Executive Officer | Buy | 4,009 | $1.41 | $5,662.51 | +2.1% | -6.5% | -37.4% | |
| Aug 26, 2022 | TMCI Treace Medical Concepts, Inc. | Treace John T.60 | Chief Executive Offer | Buy | 21,491 | $20.95 | $450,341.76 | +0.4% | +8.1% | -25.1% | |
| Aug 26, 2022 | OSUR Orasure Technologies Inc | Lancaster Ronny B | Director | Buy | 50,000 | $4.00 | $200,000.00 | +91.3% | +24.2% | +61.0% | |
| Aug 26, 2022 | BJDX Bluejay Diagnostics, Inc. | Fisher Kenneth R | Chief Financial Officer | Buy | 20,000 | $1.03 | $20,600.00 | +100.0% | -27.2% | -69.5% | |
| Aug 26, 2022 | HBIO Harvard Bioscience Inc | Loy Bertrand69 | Director | Buy | 9,291 | $3.41 | $31,682.31 | +2.4% | -26.7% | +31.0% | |
| Aug 26, 2022 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 1,767 | $4.08 | $7,216.20 | -0.3% | -10.0% | -74.9% | |
| Aug 26, 2022 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | President And CEO | Sell | 6,613 | $4.08 | $27,006.66 | -0.3% | -10.0% | -74.9% | |
| Aug 26, 2022 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 5,290 | $4.08 | $21,603.72 | -0.3% | -10.0% | -74.9% | |
| Aug 26, 2022 | RBOT Vicarious Surgical Inc. | Morris June89 | CLO, GC And Secretary | Sell | 1,747 | $4.08 | $7,134.59 | -0.3% | -10.0% | -74.9% | |
| Aug 25, 2022 | NXGL Nexgel, Inc. | Stefansky David54 | Director | Buy | 5,000 | $1.73 | $8,650.00 | +28.4% | -26.7% | +23.3% | |
| Aug 25, 2022 | ABT Abbott Laboratories | Manning Joseph J | Executive Vice President | Sell | 26,898 | $105.03 | $2,825,087.85 | -19.6% | +0.6% | -1.1% | |
| Aug 25, 2022 | ABT Abbott Laboratories | Ford Robert B | Chairman And CEO | Sell | 102,425 | $105.10 | $10,765,154.29 | -41.9% | +0.6% | -1.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.